New Outlook "Global Biosimilar Industrial Report" Market 2016, Demand, Analysis & 2020 Forecast
Description-
The
report titled “Global Biosimilar
Market: Trends & Opportunities (2015 Edition)” analyzes the
global biologics market, with exhaustive discussion on demand of
Biosimilars with increase in patent expiry of innovator drugs. The
key market challenges recognized by the analysts and the major trends
biosimilar market are presented in the report. Further, key
manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr.
Reddy’s Lab are profiled in the report.
Product
Coverage
- Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
- Humira, Enbrel, Remicade, Herceptin
- Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)
- Company Coverage
- Sandoz(Novartis)
- Hospira
- Teva
- Dr. Reddy’s Lab
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-biosimilar-market-trends-and-opportunities-2015-edition-report.html
Executive
Summary
Rising
budgetary pressures to reduce healthcare expenditures, patent
expiries of blockbuster drugs, growing demand for cost-effective
alternatives, increasing aging population, conductive government
initiatives and rising incidences of various diseases are significant
factors that are responsible for the growth of global biosimilar
market (2013 to 2018). On the other hand stringent regulatory
environment in some countries, high manufacturing complexities,
costs, and presence of low priced generic drugs and high-entry
barriers are considered to hinder the market growth. Emerging
pharmaceutical market and less stringent government regulatory
frameworks in few countries can provides some of the major
opportunities for biosimilars market. In addition, increased
collaboration between manufacturing companies and outsourcing of
biosimilar products are key trends for biosimilars market.
The
biosimilar products market is segmented into recombinant
non-glycosylated proteins, recombinant glycosylated proteins, and
recombinant peptides. Globally there are 280 biosimilars in pipeline
and their clinical trials are increasing at a rate of 20% annually.
The
report titled “The Global Biosimilar Market: Trends &
Opportunities (2014-2018)” provides an in-depth analysis of the
growing Biosimilar Market with detailed analysis of market sizing and
growth, market share and economic impact of the industry. The report
also assesses the key opportunities in the market and outlines the
factors that are and will be driving the growth of the industry.
Growth of the overall Biosimilars industry has also been forecasted
for the period 2014-18, taking into consideration the previous growth
patterns, the growth drivers and the current and future trends.
Further, key players of the industry like Sandoz, Teva, Hospira and
Dr. Reddy’s Lab are profiled.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment